Our Theory of Change
Country alignment: We build partnerships and relationships with in-country researchers, policymakers, and “evidence brokers” (those who bridge the research-policy gap).
Intense policy engagement: We conduct strategic science (“research designed to address gaps in knowledge important to policy decisions”) linked to country and donor decision-making processes and timelines.
Identifying windows of opportunity: We take advantage of windows of opportunity for influencing policy dialogues and debates, both at the national and international levels.
Multi-disciplinary approach: We draw upon a wide range of expertise and disciplines at Duke University and beyond to gain a broad understanding of global health challenges and to shape comprehensive policy solutions.
Synergies with other researchers: We work to ensure that our efforts are complementary to other ongoing projects.
Technical Focus Areas
- Development assistance for health (DAH): tracking flows, estimating financing needs, improving the impact
- Global public goods for health, including product development for neglected diseases: understanding key priorities, tracking funding flows and needs, developing new approaches to resource mobilization
- Transition in middle-income countries: understanding the implications of interlinked transitions in disease epidemiology, demography, DAH, and domestic health financing
- Achieving universal health coverage (UHC) and strengthening health systems
- The unfinished agenda of infectious diseases, and reproductive, maternal, newborn, child, and adolescent health (RMNCAH): a health systems and UHC perspective
- The emerging agenda of non-communicable diseases (NCDs) a health systems and UHC perspective
The global health landscape is undergoing a set of rapid and profound transitions that threaten to stall or even derail progress in global health improvement. The 4Ds project analyzes four of these major, inter-linked transitions—shifts in diseases, demography, development assistance for health (DAH), and domestic health financing. Learn more…
This project is studying the health and financial benefits of public investments in reproductive, maternal, newborn, adolescent, and child health (RMNACH). Learn more…
In March 2018, the government of India approved a publicly funded health insurance scheme that is officially called the Prime Minister (or Pradhan Mantri) Jan Arogya Yojana (PM-JAY), also known as Ayushman Bharat (and known colloquially as “Modicare” after Indian Prime Minister Narendra Modi). With funding from a Duke Global Health Institute pilot grant, the Center for Policy Impact in Global Health is conducting a mixed methods study on the implementation and financing of PM-JAY in Uttar Pradesh. Learn more…
In 2018, a research team from Duke University and Policy Cures Research, in collaboration with TDR, the Special Programme for Research and Training in Tropical Diseases, published the first analysis of the pipeline of products for poverty-related neglected tropical diseases (PRNTDs) using a financial modelling tool called Portfolio-to-Impact (P2I). The analysis summarized the pipeline of candidate products for PRNTDs and estimated (a) the costs to move these candidates through the pipeline, (b) the likely launches, and (c) the additional costs to launch critical “missing” products. In a new project, the Center is partnering with Policy Cures Research to update both the pipeline portfolio review and the cost modeling. Learn more…